Establishment of biotech parks
Office and plant space for investors and incubator
India is among the top 12 destinations for biotechnology in the world, with approximately 3% share in the global Biotechnology industry. The Biotechnology industry in India, comprising about 800 companies, is estimated to have grown at a CAGR of 20.3% during 2005-17, to reach $ 11.6 bn in 2016-17.
India has the second highest number of US Food & Drug Administration (USFDA)-approved manufacturing plants outside the US. The country is currently home to more than 523 USFDA approved drug manufacturing facilities.
100% FDI is allowed under the automatic route for greenfield pharma.
100% FDI is allowed under the government route for brownfield pharma in upto 74% FDI is under automatic route and beyond 74% is under the government approval route.
FDI up to 100% is allowed under the automatic route for the manufacturing of medical devices.
For further details, please refer FDI Policy
Tax deduction on R&D expenditure
Annual industrial growth
Bio-pharma revenue share
Share in Bio-services
World's largest producer of recombinant Hepatitis B vaccine
World's largest producer of BT Cotton
World's second highest number of USFDA approved plants
The sector is divided into five major segments- Bio-pharma, Bio-services, Bio-agri, Bio-industrial, and Bio-informatics. The biopharmaceutical sector accounts for the largest share of the biotech industry with a share of 64% of total revenues, followed by bio-services with 18% market share. India is becoming a leading destination for clinical trials, contract research, and manufacturing activities, which is further fuelling the growth of the bio-services sector. Bio-agri segments accounted for 14% of the biotech industry in 2015-16, while the remaining market is catered by bio-industrial (3%) and bio-informatics (1%).
Biotechnology Industry Research Assistance Council (BIRAC) is a not-for-profit set up by Department of Biotechnology (DBT), Government of India as an interface agency to strengthen and empower the emerging biotechnology enterprises to undertake strategic research and innovation.
BIRAC’s focus has been creation of a biotechnology start-up environment in the country. It has taken a couple of strategic implementation programmes that span from provide funding to early stage ideas through grants, creation of bio-incubators at strategic locations (through BioNEST) and extend mentorship and networking opportunities to start-ups (the data on map section below shows BIRAC BioNEST and BIRAC supported incubators across different states in India).
Helix investment Holdings Pte Ltd., Singapore invested $ 12 mn in Concord Biotech Ltd
Tano India Pvt., Mauritius invested $ 7.4 mn in Windlas Biotech Ltd.
Office and plant space for investors and incubator
Host of instrumentation facilities and services
India is world’s leading supplier of affordable vaccines
Industry academia collaboration for Bio-pharma development
Attracted $ 2.8 bn investments between 2012-16
The vision is to create biotechnology enterprise equipped wi…
Bio-incubation allows harnessing of the entrepreneurial pote…
The scheme was established to foster the generation of ideas…
To provide guidelines to applicants to enable them to unders…
It focuses on building coherence and connectivity between di…
The guidelines reiterate that the general principles of biom…
In order to achieve the aforementioned objectives, each inst…
Synthetic Organic Chemicals Project [Vatva]
Pharmaceutical Park at Chaygaon
Active Pharmaceutical Ingredients Project [Visakhapatnam]
Bulk Drugs Project [Chikkaballapura]
Agricultural biotechnology is an advanced technology that allows plant breeders to make precise genetic changes to impart beneficial traits to the crop plants we rely on for food and fiber.
For centuries farmers and plant breeders have labored to improve crop plants. Traditional breeding methods include selecting and sowing the seeds from the strongest, most desirable plants to produce the next generation of crops. By selecting and breeding plants with characteristics such as higher yield, resistance to pests and hardiness, early farmers dramatically changed the genetic make-up of crop plants long before the science of genetics was understood. As a result, most of today's crop plants bear little resemblance to their wild ancestors.
The tools of modern biotechnology allow plant breeders to select genes that produce beneficial traits and move them from one organism to another. This process is far more precise and selective than crossbreeding, which involves the transfer of tens of thousands of genes, and provided plant developers with a more detailed knowledge of the changes being made.
The portable plants, RCC digesters and waste to electricity plants which are designed and developed by BIOTECH have been approved by Ministry of New and Renewable Energy (MNRE), Government of India. So these types of plants installed in India are eligible for the subsidy from MNRE.
The mandate is as follows:
1) Promote large scale use of Biotechnology.
2) Support R&D and manufacturing in Biology.
3) Responsibility for Autonomous Institutions.
4) Promote University and Industry Interaction.
5) Identify and Set up Centres of Excellence for R&D.
6) Integrated Programme for Human Resource Development.
7) Serve as Nodal Point for specific International Collaborations.
8) Establishment of Infrastructure Facilities to support R&D and production.
9) Evolve Bio Safety Guidelines, manufacture and application of cell based vaccines.
10) Serve as nodal point for the collection and dissemination of information relating to biotechnology.
This technology helps plants for pest resistance, helps plants to tolerate the stressful conditions like low temperature, drought, salt in soil, etc., helps to generate vaccines for the animals to fight against diseases, it is also used to produce pharmaceuticals etc.
The NBM is an industry-academia collaborative mission for accelerating discovery research to early development for biopharmaceuticals innovate in India (I3). The aim of the mission is to enable and nurture an ecosystem for preparing India's technological and product development capabilities in biopharmaceutical to a level that will be globally competitive over the next decade, and transform the health standards of India's population through affordable product development. The department aims to achieve this through development of centres of excellence, strengthening of bio-clusters, creating shared infrastructure for product development, knowledge sharing etc.
To submit one's proposal under the NBM, access the following link with relevant details.